Rebalix
iShares · sheet of 10 September 2026
iShares · sheet of 10 September 2026ETF sheet · official issuer and register data
iShares S&P 500 3% Capped UCITS ETF
SPC3 · IE000AY6KP29 · USD · domicile Ireland
Equity · United States · Large capSFDR art. 6
Index tracked: S&P 500 3% Capped Index (USD) N
- TER
- 0.20%+ trans. 0.00%
- Fund size
- 1 m EUR
- Tracking difference
- +0.00%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingsemi-annual
Launch 14 Apr 2025 · costs from the KID as of 2 Sept 2026 · 504 securities held · 2 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a total return, through a combination of capital growth and income on the Fund’s assets , which reflects the return of the S&P 500 3% Capped Index, the Fund’s benchmark index (“Index”). The Share Class, via the Fund, is passively managed and aims to invest so far as possible and practicable in the equity securities (e.g. shares) that make up the Index. The S&P 500 3% Capped Index is designed to measure the performance of securities within the S&P 500 Index (the “Parent Index”) with a 3% cap…
Performance since series start (in euro) — base 100
14 Apr 2025 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +20.3% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +38.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.10% | 12.10% | — |
| Max drawdown | −8.41% | −8.41% | — |
| Sharpe | 1.20 | 1.20 | — |
| Sortino | 1.74 | 1.74 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · SPC3 · IE000AY6KP291
RebalixSPC3 · IE000AY6KP29 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · declared by the issuer
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +0.00% | +0.00% | +0.00% |
| 2024 | +0.00% | +0.00% | +0.00% |
| 2023 | +0.00% | +0.00% | +0.00% |
| 2022 | +0.00% | +0.00% | +0.00% |
| 2021 | +0.00% | +0.00% | +0.00% |
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 0.06 USD (0.84% of NAV) · last ex-date 20 Aug 2026
| Year | Payments | Total (USD) |
|---|---|---|
| 2026 | 2 | 0.06 |
| 2025 | 1 | 0.02 |
Holdings
Portfolio as declared by the issuer · 31 Aug 2026 · 504 securities · top-10 weight = 25.4%
| Top holdings | Weight |
|---|---|
| 3.6% | |
| 3.1% | |
| 3.1% | |
| 3.1% | |
| 2.8% | |
| 2.3% | |
| 2.0% | |
| 1.9% | |
| 1.8% | |
| 1.7% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
4SH0 · Börse Hamburg, Börse München / gettex
+ 10 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE000AY6KP29
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000AY6KP29
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · SPC3 · IE000AY6KP292